Baird Medical Investment Holdings (BDMDW) Non-Current Deffered Revenue (2023)
Baird Medical Investment Holdings' quarterly Non-Current Deffered Revenue came in at $875258.0 in Q4 2023.
Baird Medical Investment Holdings has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $875258.0 in Q4 2023.
- For the quarter ending Q4 2023, Non-Current Deffered Revenue changed N/A year-over-year to $875258.0; the trailing twelve-month figure through Dec 2023 stood at $875258.0 (changed N/A YoY), and the FY2023 full-year result was $875258.0, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q4 2023 stood at $875258.0.
- The five-year high for Non-Current Deffered Revenue was $875258.0 in Q4 2023, with the low at $875258.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Baird Medical Investment Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 875,258.00 |